The document discusses the active constituents of Trigonella foenum-gracum (fenugreek) that are used in diabetic therapy. It identifies five major active constituents: flavonoids, 4-hydroxyisoleucine, steroidal saponins, trigonelline, and galactomannan. Each constituent is described in terms of its chemical structure, mechanism of action in reducing blood glucose levels, and potential role in treating diabetes.